Real-Life Analysis with Erenumab: First Target Therapy in the Episodic and Chronic Migraine’s Prophylaxis

Background: to research retrospectively the efficacy of Erenumab’s treatment, thus allowing to describe a summary more in line with the reality observed every day in clinical practice, relative to a sample of patients widely heterogeneous. The study aims to confirm the efficacy of Erenumab, in terms...

Descripción completa

Detalles Bibliográficos
Autores principales: Maraia, Zaira, Ricci, Diletta, Rocchi, Marco Bruno Luigi, Moretti, Alessandro, Bufarini, Celestino, Cavaliere, Arturo, Peverini, Manola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509525/
https://www.ncbi.nlm.nih.gov/pubmed/34640442
http://dx.doi.org/10.3390/jcm10194425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509525/
https://www.ncbi.nlm.nih.gov/pubmed/34640442
http://dx.doi.org/10.3390/jcm10194425

Ejemplares similares